Research and Markets: Global Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Development Pipeline Review, H1 2015 - 16 Drug Profiles & 11 Companies

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/kt2zpx/basal_cell) has announced the addition of the "Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • 4SC AG
  • Biofrontera AG
  • Biogenomics Limited
  • Biosceptre International Limited
  • Bristol-Myers Squibb Company
  • Genextra S.p.a.
  • MediGene AG
  • Novartis AG
  • Oncovir, Inc.
  • Redx Pharma Ltd
  • Transgene SA

Drug Profiles

  • aminolevulinic acid hydrochloride
  • BIL-010t
  • BMS-833923
  • CIGB-128
  • CS-S/BCC-1
  • CS-TATI-1
  • DAC-060
  • erismodegib
  • interferon alfa-2b (recombinant)
  • LEQ-506
  • Oshadi D + Oshadi R
  • Poly-ICLC
  • sinecatechins
  • Small Molecule to Inhibit Smoothened Receptor for Basal Cell Carcinoma
  • Small Molecules to Inhibit Casein Kinase 1 for Cancer
  • TG-1042

For more information visit http://www.researchandmarkets.com/research/kt2zpx/basal_cell

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology